Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
73.74
+0.48 (0.66%)
Mar 9, 2026, 1:46 PM EDT - Market open
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 370 employees as of December 31, 2025. The number of employees increased by 47 or 14.55% compared to the previous year.
Employees
370
Change (1Y)
47
Growth (1Y)
14.55%
Revenue / Employee
$1,219,892
Profits / Employee
-$179,508
Market Cap
3.14B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Denali Therapeutics | 503 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Alumis | 223 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
| IDEAYA Biosciences | 145 |
| Viridian Therapeutics | 143 |
TARS News
- 10 days ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential - Seeking Alpha
- 13 days ago - Tarsus Pharmaceuticals, Inc. (TARS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - GlobeNewsWire
- 19 days ago - Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - GlobeNewsWire
- 4 weeks ago - Allspring Emerging Growth Fund Q4 2025 Performance Review - Seeking Alpha
- 3 months ago - Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 - Seeking Alpha
- 4 months ago - Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call Transcript - Seeking Alpha